Ebag, Yushen Rey .
HRN: 25-77-71 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/26/2024
CEFUROXIME 750MG (VIAL)
08/26/2024
09/02/2024
IVT
600 Mg
Q 8h
Abdominal Mass
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes